Deltex Medical Group Plc
| London Stock Exchange: DEMG
Deltex Medical Group Plc operates through its subsidiaries which engages in research, development, manufacture and sale of Oesophageal Doppler Haemodynamic Monitoring Systems. Deltex Medical's CardioQ-ODM oesophageal Doppler monitor (ODM) changes the way doctors can care for patients having major surgery or in intensive care.ODM is the only technology to measure blood flows in the central circulation; it is highly sensitive to changes in flow and measures them immediately and accurately. The company's business operates through four segments: UK, USA, Spain and International. Deltex Medical Group was founded on January 6, 2000 and is headquartered in Chichester, the United Kingdom.